Exceeding Enrollment Goals in a Phase 3 Severe Hypertriglyceridemia Study
Study Objectives Study enrollment goal of 300 participants across 140 sites, across 17 countries. Alliance Clinical Network Goal: Enroll 1 […]
Study Objectives Study enrollment goal of 300 participants across 140 sites, across 17 countries. Alliance Clinical Network Goal: Enroll 1 […]
Study Objectives Enrollment of 416 participants, across 100 sites, study wide Alliance Clinical Network Goal: Enroll 10 participants ChallengesDuring the
Study Objectives Enrollment of 250 participants, across 100 sites, study wide Alliance Clinical Network Goal: Enroll 10 participants in 6
As clinical studies become more complex and timelines contract, clinical research sites face pressure to deliver high-quality data, remain compliant,
Skin conditions are among the most common health issues worldwide, increasing the demand for effective, long-lasting treatments. In the US,
Study Objectives Competitive enrollment of 5,000 participants across multiple sites, within a 48-month enrollment window. Alliance Clinical Network Goal: Enroll
Conducting clinical trials in Type 2 Diabetes (T2D) presents a unique set of challenges at the site level. Sites are
The following table provides a brief history of GLP-1 therapies that have received FDA regulatory approval. In addition to identifying brand name,
Study Objectives Enroll 4,000 participants across multiple global sites. Alliance Clinical Network Goal: Enroll 300 participants (150 per site) within
Achieving diversity in clinical trials is critical to ensuring safe, effective therapies and equitable health outcomes, as well as fostering